Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 38

Results For "RSE"

1400 News Found

Venus Remedies gets huge global acclaim with UNICEF GMP approval
News | March 12, 2024

Venus Remedies gets huge global acclaim with UNICEF GMP approval

Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF


Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas
Diagnostic Center | March 12, 2024

Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas

With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained


CAPFIMS to provide opportunity for medical graduates and specialists to serve in the medical cadre of CAPFs
Policy | March 11, 2024

CAPFIMS to provide opportunity for medical graduates and specialists to serve in the medical cadre of CAPFs

The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.


North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh
Policy | March 11, 2024

North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh

The institution will be spread over an area of more than 8 acres


LVPEI observes World Glaucoma Week
Healthcare | March 11, 2024

LVPEI observes World Glaucoma Week

Vision loss due to Glaucoma can be prevented if it is detected and treated early


Women's integral role in India's US$ 5 trillion ambition
News | March 11, 2024

Women's integral role in India's US$ 5 trillion ambition

Women emerge as the cornerstone of this monumental undertaking


Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility
Drug Approval | March 09, 2024

Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility

The inspection was concluded with few procedural observations


India approves Rs. 10,300 crore for AI Mission
Digitisation | March 08, 2024

India approves Rs. 10,300 crore for AI Mission

The investment will catalyse various components of the IndiaAI Mission


Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
Policy | March 07, 2024

Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme

The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics


Nectar Lifesciences’ suo moto clarification on a news item
News | March 07, 2024

Nectar Lifesciences’ suo moto clarification on a news item

Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs